| Dr Elizabeth L Chua, MD | |
|
300 Medical Center Dr, 102, Gadsden, AL 35903-1157 | |
| (303) 876-7243 | |
| Not Available |
| Full Name | Dr Elizabeth L Chua |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 31 Years |
| Location | 300 Medical Center Dr, Gadsden, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134117872 | NPI | - | NPPES |
| 02635069 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | MD32047 (Alabama) | Primary |
| 207R00000X | Internal Medicine | MD32047 (Alabama) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Medical Center South | Montgomery, AL | Hospital |
| Prattville Baptist Hospital | Prattville, AL | Hospital |
| Jackson Hospital & Clinic Inc | Montgomery, AL | Hospital |
| Troy Regional Medical Center | Troy, AL | Hospital |
| Baptist Medical Center East | Montgomery, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Renal Associates Of Montgomery, P.c. | 6608894019 | 8 |
News Archive
Cancer Research UK scientists have discovered how giving a class of drugs called AKT inhibitors in combination with radiotherapy might boost its effectiveness across a wide range of cancers, according to a study published in the Journal of Clinical Investigation today.
Resource Systems, developer of long-term care electronic documentation system CareTracker, and Extendicare Health Services, Inc., a leading provider of senior care with over 260 health centers across U.S. and Canada, announce Extendicare's commitment to introduce the new CareTracker Clinical Intelligence technology to 187 health centers. The Clinical Intelligence tool assists health centers in predicting and notifying caregivers of potential resident care issues before they become a problem.
A new technology in the Neonatal Intensive Care Unit at UC San Diego Health is able to predict the risk of life-threatening infections up to 24 hours before they appear in severely premature or critically ill infants. Infection is the leading cause of death in this fragile patient population.
Incyte Corporation (NASDAQ: INCY) announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterized by varying degrees of bone marrow failure, splenic enlargement and debilitating constitutional symptoms, and INCB28060, an oral cMET inhibitor that is about to enter Phase I development as a potential treatment for multiple cancers.
Chronic occupational exposure to organic solvents, found in materials such as paints, printing and dry cleaning agents, is widespread all over the world, and is thought to damage the central nervous system.
› Verified 5 days ago
| Entity Name | Renal Associates Of Montgomery, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881659423 PECOS PAC ID: 6608894019 Enrollment ID: O20051103001127 |
News Archive
Cancer Research UK scientists have discovered how giving a class of drugs called AKT inhibitors in combination with radiotherapy might boost its effectiveness across a wide range of cancers, according to a study published in the Journal of Clinical Investigation today.
Resource Systems, developer of long-term care electronic documentation system CareTracker, and Extendicare Health Services, Inc., a leading provider of senior care with over 260 health centers across U.S. and Canada, announce Extendicare's commitment to introduce the new CareTracker Clinical Intelligence technology to 187 health centers. The Clinical Intelligence tool assists health centers in predicting and notifying caregivers of potential resident care issues before they become a problem.
A new technology in the Neonatal Intensive Care Unit at UC San Diego Health is able to predict the risk of life-threatening infections up to 24 hours before they appear in severely premature or critically ill infants. Infection is the leading cause of death in this fragile patient population.
Incyte Corporation (NASDAQ: INCY) announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterized by varying degrees of bone marrow failure, splenic enlargement and debilitating constitutional symptoms, and INCB28060, an oral cMET inhibitor that is about to enter Phase I development as a potential treatment for multiple cancers.
Chronic occupational exposure to organic solvents, found in materials such as paints, printing and dry cleaning agents, is widespread all over the world, and is thought to damage the central nervous system.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth L Chua, MD 2000 16th St, Denver, CO 80202-5117 Ph: (303) 876-7243 | Dr Elizabeth L Chua, MD 300 Medical Center Dr, 102, Gadsden, AL 35903-1157 Ph: (303) 876-7243 |
News Archive
Cancer Research UK scientists have discovered how giving a class of drugs called AKT inhibitors in combination with radiotherapy might boost its effectiveness across a wide range of cancers, according to a study published in the Journal of Clinical Investigation today.
Resource Systems, developer of long-term care electronic documentation system CareTracker, and Extendicare Health Services, Inc., a leading provider of senior care with over 260 health centers across U.S. and Canada, announce Extendicare's commitment to introduce the new CareTracker Clinical Intelligence technology to 187 health centers. The Clinical Intelligence tool assists health centers in predicting and notifying caregivers of potential resident care issues before they become a problem.
A new technology in the Neonatal Intensive Care Unit at UC San Diego Health is able to predict the risk of life-threatening infections up to 24 hours before they appear in severely premature or critically ill infants. Infection is the leading cause of death in this fragile patient population.
Incyte Corporation (NASDAQ: INCY) announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterized by varying degrees of bone marrow failure, splenic enlargement and debilitating constitutional symptoms, and INCB28060, an oral cMET inhibitor that is about to enter Phase I development as a potential treatment for multiple cancers.
Chronic occupational exposure to organic solvents, found in materials such as paints, printing and dry cleaning agents, is widespread all over the world, and is thought to damage the central nervous system.
› Verified 5 days ago
Dr. Peter Ming Szeto, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1102 Goodyear Ave, Gadsden, AL 35903 Phone: 256-492-9924 Fax: 256-492-9965 | |
Dr. James N Wallace, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 512 S 4th St, Gadsden, AL 35901 Phone: 256-547-2255 Fax: 256-547-2257 | |
Jed L Kaplan, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 900 Goodyear Ave, Suite A, Gadsden, AL 35903 Phone: 256-492-3220 Fax: 256-492-3759 | |
Dr. George Bruce Head Iii, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1102 Goodyear Ave, Gadsden, AL 35903 Phone: 256-492-9924 Fax: 256-492-9965 | |
Dr. Muhammad Tariq, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1411 Piedmont Cutoff, Gadsden, AL 35903 Phone: 256-492-0131 | |
Sabrina Nicole Morgan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 851 Goodyear Ave, Gadsden, AL 35903 Phone: 800-780-4146 Fax: 256-494-5063 | |
Vijayaprasad Tummala, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 900 Goodyear Ave, Suite A, Gadsden, AL 35903 Phone: 256-492-3220 Fax: 256-492-3759 |